Table IV.
Group | Marker | D0 | D1 | D3 | D5 | D7 |
---|---|---|---|---|---|---|
Control | AST | 41.28±11.39 | 188.46±29.19a,c | 152.93±34.62a,c | 90.63±23.64a,c | 47.41±13.64 |
ALT | 47.13±12.84 | 196.11±32.75a,c | 160.37±34.51a,c | 99.82±25.77a,c | 49.63±14.96 | |
TBIL | 15.24±7.93 | 19.81±8.1a,c | 24.14±8.69a,c | 27.59±10.67a,c | 16.17±7.81 | |
Experimental | AST | 39.52±12.63 | 154.82±26.39b,c | 129.86±25.19b,c | 72.47±19.78b,c | 40.42±10.56 |
ALT | 45.21±11.83 | 161.14±31.46b,c | 131.43±30.31b,c | 75.97±20.73b,c | 42.55±11.87 | |
TBIL | 15.87±8.44 | 17.15±7.88b,c | 22.97±8.13b,c | 18.77±9.64b,c | 15.93±8.11 |
P<0.05, compared with D0 within the control group
P<0.05, compared with D0 within the experimental group
P<0.05, compared with the same day in the other group. AST, aspartate aminotransferase; ALT, alanine aminotransferase; TBIL, total bilirubin.